Sign inJoin waitlistJoin the waitlist

Roland Chu

Program Director · Central Michigan University College of Medicine/CMU Medical Education Partners

Credentials: · ·

History

Central Michigan University College of Medicine/CMU Medical Education Partners
Present
/ of Staff · Children's Hospital of Michigan
Present
Central Michigan University College of Medicine/CMU Medical Education Partners
Present

Pediatric Hematology/Oncology
Emory University School of Medicine
2003–2006
Wayne State University
2000–2003
Children's Hospital of Michigan
1999–2000
Wayne State University School of Medicine
1995–1999

Research

Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells
Clinical Cancer Research · 2016 · 214 citations
Use of replicating oncolytic adenoviruses in combination therapy for cancer
Review · Clinical Cancer Research · 2004 · First of 4 authors · 138 citations
Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers?
Journal of Cancer Survivorship · 2014 · 87 citations

Jeffrey Taub
7 papers
Maxim Yankelevich
6 papers
Sureyya Savasan
4 papers
YR
Yaddanapudi Ravindranath
4 papers
ZW
Zhihong Wang
4 papers
Eric McGrath
3 papers · 1 as a fellow
Alissa Martin
2 papers
AS
Anthony Shields
2 papers
CL
Charles Lynch
2 papers
Daniel Lee
2 papers
JS
Jessica Spruit
2 papers
Kanta Bhambhani
2 papers

Clinical trials

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2018–2030
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Site PI · Recruiting · Phase 3
Children's Oncology Group
2017–2027
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
Site PI · Recruiting · Phase 2
New York Blood Center
2012–2030
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
Sub-investigator · Unknown
Barbara Ann Karmanos Cancer Institute
2011–2018